SEARCH

SEARCH BY CITATION

References

  • 1
    O'Grady JG, Smith HM, Davies SE, Daniels HM, Donaldson PT, Tan KC, Portmann B, et al. Hepatitis B virus reinfection after orthotopic liver transplantation. J Hepatol 1992; 14:104111.MEDLINE
  • 2
    Todo S, DeMetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991; 13:619626.MEDLINE
  • 3
    Belle HS, Beringer KC, Detre KM. An update on liver transplantation in the US: recipient characteristics and outocme. In: Terasaki-Cecha eds. Clinical Transplants. Los Angeles: UCLA Tissue Typing Laboratory. 1995;115.
  • 4
    Chazouilleres O, Mamish D, Kim M, Carey K, Ferrell L, Roberts JP, Ascher NL, et al. “Occult” hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994; 343:142146.MEDLINE
  • 5
    Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329:18421847.MEDLINE
  • 6
    Poterucha JJ, Wiesner RH. Liver transplantation and hepatitis B. Ann Intern Med 1997; 126:805807.MEDLINE
  • 7
    Medicare program: criteria for Medicare coverage of adult liver transplants-HCFA. Final notice. Fed Regist 1991; 56:1500615018.MEDLINE
  • 8
    Tur-Kaspa R, Burk RD, Shaul Y, Shafritz DA. Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Scie U S A 1986; 83:16271633.
  • 9
    Perrillo RP. Interferon in the management of chronic hepatitis B. Dig Dis Sci 1993; 38:577593.MEDLINE
  • 10
    Rakela J, Wooten RS, Batts KP, Perkins JD, Taswell HF, Krom RAF. Failure of interferon to prevent recurrent hepatitis B infection in hepatic allograft. Mayo Clin Proc 1989; 64:429432.MEDLINE
  • 11
    Terrault NA, Holland CC, Ferrell L, Hahn JA, Lake JR, Roberts JP, Ascher NL, et al. Interferon alfa for recurrent hepatitis B infection after liver transplantation. Liver Transplant Surg 1996; 2:132138.
  • 12
    Tyrrell DLJ, Fischer K, Sayani K, Tan W, Jewell L. Treatment of chimpanzees and ducks with lamivudine, 2′3′-dideoxy-3′-thiacytidine results in a rapid suppression of hepadnaviral DNA in sera [Abstract]. Clini Invest Med 1993; 16:B77.
  • 13
    Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333:16571661.MEDLINE
  • 14
    Lai CL, Liaw YF, Leung N, Chang TT, Guan B, Tai DI, Ng KY, et al. Lamivudine therapy for chronic hepatitis B infection: a 12 months placebo-controlled, double-blind, multicentre study [Abstract]. J Hepatology 26(suppl 1):79.
  • 15
    Grellier L, Mutimer D, Ahmed M, Brown D, Burroughs AK, Rolles K, McMaster P, et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996; 348:12121215.MEDLINE
  • 16
    Allen MI, Deslauriers M, Andrews CW, Baldanti F, Tipples GA, Walters KA, Tyrrell DLJ, et al. Identification and biologic characterization of mutations in HBV resistant to lamivudine [Abstract]. Hepatology 26(suppl):12121215.
  • 17
    Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1:431435.MEDLINE
  • 18
    Conover WJ. Practical nonparametric statistics. New York: Wiley. 1980;280282, 122–128.
  • 19
    Villamil FG, Vierling JM. Recurrence of viral hepatitis after liver transplantation: insights into management. Liver Transpl Surg 1995; 1:8999.MEDLINE
  • 20
    Gish RG, Lau JYN, Brooks L, Fang JWS, Steady SL, Imperial JC, Garcia-Kennedy R, et al. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology 1996; 23:17.MEDLINE
  • 21
    Kruger M, Tillmann HL, Trautwein C, Bode V, Oldhafer K, Maschek H, Boker KHW, et al. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study. Liver Transplant Surg 1996; 2:253262.
  • 22
    Davies SE, Portmann BC, O'Grady JG, Aldis PM, Chagger K, Alexander GJM, Williams R, et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique patten of fibrosing cholestatic hepatitis. Hepatology 1991; 13:150157.MEDLINE
  • 23
    Chisari FV, Ferrari C. Hepatitis B virus inmunopathology. Springer Semin Immunopathol 1995; 17:261281.MEDLINE
  • 24
    Bartholomew MM, Jansen RW, Jeffers LJ, Reddy KR, Johnson LC, Bunzendahl H, Condreay LD, et al. Hepatitis B virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 1997; 349:2022.MEDLINE
  • 25
    Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DLJ. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 1996; 24:714717.MEDLINE
  • 26
    Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC, McDade H. Viral dynamics in hepatitis B virus infection. Proc Nat Acad Sci U S A 1996; 93:43984402.
  • 27
    Lai CL, Chien RN, Leung NWY, Chang TT, Guan R, Tai DI, Ng KY, et al. A one year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998; 339:6168.MEDLINE
  • 28
    Melegari M, Scaglioni PP, Wands JR. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology 1997; 27:628633.
  • 29
    Colledge D, Locarnini S, Shaw T. Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitro. Hepatology 1997; 26:216225.MEDLINE
  • 30
    Perrillo R, Rakela J, Martin P, Wright T, Levy G, Schiff E, Dienstag J, et al. Lamivudine for suppression and/or prevention of hepatitis B when given pre/post liver transplantation [Abstract]. Hepatology 26(suppl):216225.
  • 31
    McGory RW, Ishitani MB, Oliveira WM, Stevenson WC, McCullough CS, Dickson RC, Caldwell SH, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996; 61:13581364.MEDLINE